Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-05 Platt Jon B. 10% owner Conversion +90,218 90,318
2017-07-05 Platt Jon B. 10% owner Conversion · Series C-2 Preferred Stock −211,930 0
2017-07-05 Platt Jon B. 10% owner Conversion · Series D Preferred Stock −127,158 0
2017-07-05 Platt Jon B. 10% owner Conversion · Series E Preferred Stock −298,500 0
2017-07-05 Platt Jon B. 10% owner Conversion · Series E-1 Preferred Stock −258,912 0
2017-07-05 ROCHE HOLDING LTD 10% owner Conversion +579,093 582,963
2017-07-05 ROCHE HOLDING LTD 10% owner Purchase +119,400 $15.00 $1.8M 702,363
2017-07-05 ROCHE HOLDING LTD 10% owner Conversion · Series D Preferred Stock −3,390,885 0
2017-07-05 ROCHE HOLDING LTD 10% owner Conversion · Series E-2 Preferred Stock −735,775 0
2017-07-05 ROCHE HOLDING LTD 10% owner Conversion · Series E-3 Preferred Stock −638,194 0
2017-07-05 ROCHE HOLDING LTD 10% owner Conversion · Series F Preferred Stock −989,594 0
2017-07-05 CVF, LLC 10% owner Conversion +536,180 536,180
2017-07-05 CVF, LLC 10% owner Purchase +180,000 $15.00 $2.7M 716,180
2017-07-05 CVF, LLC 10% owner Conversion · Series E-3 Preferred Stock −4,411,765 0
2017-07-05 CVF, LLC 10% owner Conversion · Series F Preferred Stock −916,262 0
2017-07-05 Kapnick Scott Director Conversion +285,438 295,076
2017-07-05 Kapnick Scott Director Purchase +159,307 $15.00 $2.4M 454,383
2017-07-05 Kapnick Scott Director Purchase +66,666 $15.00 $1000K 521,049
2017-07-05 Kapnick Scott Director Conversion · Series D Preferred Stock −106,856 0
2017-07-05 Kapnick Scott Director Conversion · Series D-1 Preferred Stock −363,636 0

Page 15 of 16 · 320 trades